Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Roche Holding AG Akt 1.04% CHF232.83B ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

As of 3:14:09 p.m. EST. Market Open.

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

300601.SZ Shenzhen Kangtai Biological Products Co., Ltd.

11, 2025 — Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle ... such as strengthening the ... Drug May Counteract Muscle Loss and Osteoporosis ...

After hours: 7:59:01 p.m. EST ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...